What are the paracrine signaling mechanisms of mesenchymal stem cells in Alzheimer's disease?

Mesenchymal stem cells operate primarily through paracrine signaling—secreting growth factors, cytokines, and exosomes that modulate the local neural microenvironment, reduce neuroinflammation and support synaptic integrity. These mechanisms are central to the adjunctive approach for Alzheimer's disease. (Informational only. Consult your neurologist.)

How do MSCs modulate immune response and neuroinflammation in Alzheimer's?

MSCs exert immunomodulatory effects by shifting microglia from pro‑inflammatory (M1) to anti‑inflammatory (M2) phenotypes, reducing pro‑inflammatory cytokine production and promoting regulatory T‑cell activity. This helps control neuroinflammation associated with Alzheimer's pathology. (Mechanism description. Research ongoing.)

Is this stem cell approach FDA‑approved for Alzheimer's?

No. This adjunctive supportive approach is not FDA‑approved and is considered investigational in the United States. It is performed under licensed physician supervision in Mexico, following COFEPRIS regulations. Patients should continue all conventional treatments as prescribed by their neurologist. (Disclosure.)

What are the clinical eligibility considerations for this supportive framework?

Eligibility requires a documented diagnosis of Alzheimer's disease by a neurologist, comprehensive medical evaluation, absence of contraindications, commitment to participate in MSC, physical therapy & nutrition components, realistic expectations, willingness to undergo pre‑therapy assessments, and continuation of conventional Alzheimer's treatments under neurologist guidance.

How do physical therapy and nutritional medicine integrate with MSC support?

Physical therapy maintains functional capacity, reduces fall risk, and supports mobility. Nutritional medicine addresses metabolic and nutritional status, providing targeted anti‑inflammatory nutrition and mitochondrial support. Together with MSC mechanisms, they form a coordinated adjunctive strategy.

Adjunctive Framework: Core & Supportive Modalities

Functional medicine approach integrated with ongoing neurological care.

Umbilical Cord Mesenchymal Stem Cells

Core adjunctive component. Umbilical cord MSCs are used for immunomodulatory and anti‑inflammatory properties to support neural tissue homeostasis.

Learn More

Physical Therapy Integration

Individualized rehabilitation to maintain functional capacity, reduce fall risk, and support mobility. Integrated with regenerative therapy.

Explore Protocols

Nutritional Medicine Support

Assessment of metabolic and nutritional status, targeted anti‑inflammatory nutrition, mitochondrial support.

Get Personalized Plan

Therapeutic Rationale: MSC Working Dynamics

Umbilical cord‑derived mesenchymal stem cells secrete bioactive molecules (cytokines, growth factors, exosomes) that influence the local neuroinflammatory environment through paracrine signaling and immune modulation.

When integrated with a structured physical therapy protocol and nutritional medicine protocol, this approach represents a coordinated adjunctive strategy rather than a stand‑alone intervention.

Minimally invasive administration techniques maximize cellular delivery while minimizing discomfort, consistent with contemporary practice for cellular therapies.

Scientific illustration
of paracrine signaling & exosome communication

Clinical Eligibility Considerations

Our clinical team evaluates several factors when assessing patients for this adjunctive approach:

Documented diagnosis of Alzheimer's disease by a neurologist
Comprehensive medical evaluation for overall health status
Absence of contraindications to cellular therapy procedures
Commitment to participate in MSC, physical therapy & nutrition components
Realistic understanding of supportive goals and expected timeframe
Willingness to undergo pre‑therapy assessments including cognitive testing
Continuation of conventional Alzheimer's treatments under neurologist guidance

Patients considering this adjunctive framework should maintain their current Alzheimer's management regimen (cholinesterase inhibitors, memantine, etc.) until a complete evaluation and coordinated plan has been established with our medical team and their primary neurologist.

Schedule a Virtual Consultation Contact us to arrange an initial conversation with a specialist.

Clinical Reference Guide

Download our complementary overview of mesenchymal stem cell mechanisms in Alzheimer's disease — no sign-up required.

Download PDF Resource

File retrieved from /resources · Immediate download · No personal data collected

Medical Director, Nexus Stem Cells

Leading our clinical team with expertise in regenerative medicine and neurological supportive care.

Meet Our Providers

Clinical Evaluation Pathway · Alzheimer's Support Framework

Comprehensive medical assessment prior to adjunctive framework consideration

Primary Neurological Consultation

Evaluation with regenerative medicine specialist, review of current Alzheimer's treatments, determination of eligibility.

Clinical Information Session

Detailed discussion of MSC mechanisms, physical/nutrition protocols, procedural steps, realistic goals.

Medical Records Review

Assessment of neurological records, prior interventions, current cognitive status (MMSE/MoCA).

We're Here to Support Your Journey

Contact Us to Learn More

Full Name *

Please enter a valid name.

Phone Number *

Please enter a valid phone number.

Preferred Day of Contact *

Please select a preferred day.

Preferred Contact Time

Email Address *

Please enter a valid email address.

Time Zone *

Please select your time zone.

Area of Concern *

Please select an area.

Preferred Contact Method * : Email Phone WhatsApp

Describe Your Health Concern *

Please describe your concern (minimum 10 characters).

What is 2 + 2?

Incorrect answer. Please try again.

Privacy Notice & Consent:

You must agree to the Privacy Notice to submit.

Mesenchymal Stem Cell Mechanisms for Alzheimer's DiseaseSupportive Framework for Cognitive Preservation